J&J’s HIV Therapy Etravirine Shown To Have Antiviral Activity In Phase III Studies
Two Phase III trials found significantly more patients taking the non-nucleoside reverse transcriptase inhibitor reached undetectable viral load.
Two Phase III trials found significantly more patients taking the non-nucleoside reverse transcriptase inhibitor reached undetectable viral load.